Further in vitro and in vivo studies with a larger cohort of gastric tumor samples will provide a better understanding of the complexity of the effect of different ligands on the regulation of the AhR pathways and may contribute to the development of novel clinically relevant agonists or antagonists. The gene discussed is AHR; the disease is gastric neoplasm.